Menu
Back to User profile » Dr Yu-Ching Lin
Papers published by Dr Yu-Ching Lin:
The Intention of Inhaled Medication Adherence Scale (IMAS): The Development of a New Instrument for Assessing Inhaled Medication Adherence Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Using Theory of Planned Behavior
Wang YH, Yang TM, Hung MS, Lin YC, Fang TP, Kuo TT, Griffiths MD, Lin CY
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1655-1664
Published Date: 2 August 2023
Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer
Chung YS, Lin YC, Hung MS, Ho MC, Fang YH
OncoTargets and Therapy 2022, 15:1563-1571
Published Date: 28 December 2022
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
Ho MC, Chung YS, Lin YC, Hung MS, Fang YH
OncoTargets and Therapy 2022, 15:1573-1582
Published Date: 28 December 2022
Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy
Fang YH, Hsieh MJ, Hung MS, Lin YC, Kuo LT, Lu ML, Tzang BS, Chen VCH
Neuropsychiatric Disease and Treatment 2020, 16:2103-2109
Published Date: 17 September 2020
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
Fang YH, Yang YH, Hsieh MJ, Hung MS, Lin YC
Cancer Management and Research 2019, 11:8539-8546
Published Date: 19 September 2019
In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically
Lung J, Chen KL, Hung CH, Chen CC, Hung MS, Lin YC, Wu CY, Lee KD, Shih NY, Tsai YH
Drug Design, Development and Therapy 2017, 11:3281-3290
Published Date: 16 November 2017
Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer
Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC
OncoTargets and Therapy 2017, 10:5173-5177
Published Date: 25 October 2017